Cellegy Pharmaceuticals Report issue

For profit Phase 3
Founded: Boyertown PA United States (1989)
Status: Acquired by Adamis Pharmaceuticals Corporation (2008)

Organization Overview

First Clinical Trial
1996
NCT00004690
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1996

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

lauric acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ichthyosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1